1.No.1 Military Medical Project-based realty management system for barracks of military hospital
Jie LIAO ; Guangzhi ZHANG ; Zongran ZHANG ; Daofeng WU ; Ailan LIU
Chinese Medical Equipment Journal 1989;0(03):-
The informatization of the realty management for barracks of the military hospital is fulfilled based on No.1 Military Medical Project, and thus the interacting management of barracks can be performed by the administration and the departments together.
2.Inhibitory function of Tregs via soluble FGL2 in chronic hepatitis B.
Li, XU ; Daofeng, YANG ; Yanlin, LIU ; Di, WU ; Xiaojing, WANG ; Qin, NING
Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(4):540-5
CD4(+)CD25(+)CD127(dim/-) regulatory T cells (Tregs) have been implicated in suppressing T cell immune responses to hepatitis B virus (HBV), but the inhibition mechanism has not being clear yet. This study investigated the effects of soluble FGL2 (sFGL2) secreted by Tregs on immune suppression in chronic HBV-infected patients. We verified that sFGL2 protein and mRNA were highly expressed in Tregs. The separated Tregs by using magnetic beads from peripheral blood mononuclear cells (PBMCs) in 20 patients with chronic hepatitis B were co-cultured with PBMCs at a ratio of 1:3 with anti-CD3 stimulating antibody or FGL2 blocking antibody. The proliferation index of CD8(+)T cells after blocking FGL2 was higher than that in blank group (3.58±0.18 vs. 3.28±0.17, P=0.034) in 18 of 20 samples, and lower than that in CD3 stimulation group (3.82±0.19, P=0.026) in 16 of 20 samples. The IFN-γ secreted in the mixed culture in the absence of Tregs was higher than that in the culture in the presence of Tregs, but it could be abolished by FGL2 blocking antibody. These results suggest that sFGL2 protein secreted by Tregs suppresses the proliferation and function of CD8(+) T cells in chronic hepatitis B.
3.MRI findings of congenital dysosmia
Hui YOU ; Feng FENG ; Jianfeng LIU ; Xueyan WU ; Jian WANG ; Daofeng NI ; Hongyi SUN ; Jun CHEN ; Zhengyu JIN
Chinese Journal of Radiology 2009;43(6):585-589
Objective To study the MRI findings of congenital dysosmia. Methods Forty-seven patients with congenital dysosmia (39 with Kallmann syndrome and 8 with isolated dysosmia) and 21 normal volunteers underwent MRI examination. The features of congenital malformation were recorded. The volume of olfactory bulbs, depth of olfactory sulei as well as diameters of pituitary glands and stalks were measured. The rate of dysplasia of olfactory bulbs and tracts in the two patients groups was compared with χ2 test. The difference of volume of olfactory bulbs between the two groups was evaluated with nonparametrie test. And the difference of diameters of pituitary glands and stalks was analyzed with analysis of variance. Results All the patients had abnormal findings in olfactory bulbs, tracts and/or olfactory sulci on MR images. The patterns of congenital malformation may be dysplastic or hypoplastic, symmetric or asymmetric. The proportion of patients with dysplasia of olfactory bulbs and tracts in Kallmann syndrome patients ( 31/39 ) was higher than that in isolated dysosmia ones ( 2/8 ) ( χ2= 6. 998, P = 0. 008 ), and the olfactory bulbs' volume of patients with Kallmann syndrome ( median 8 mm3 ) was smaller than that of patients with isolated dysosmia ( median 22 mm3 ) ( Z = - 2. 902, P = 0. 004 ). The pituitary glands were smaller and the stalks were thinner in patients with Kallmann syndrome than those in volunteers [ the anteroposterior diameter of pituitary glands in Kallmann syndrome (7. 22±1.93) mm, that in normal volunteers (9. 94±1.59) ram, F=16.835, P=0. 000; height of pituitary glands in Kallmann syndrome (3.71±1.74) mm, that in normal volunteers (6. 00±1.24) ram, F = 16. 092, P = 0. 000; the anteroposterior diameter of pituitary stalks in Kallmann syndrome ( 1.19±0. 55 ) mm, that in normal volunteers ( 1.88±0. 49 ) mm, F = 13.060, P =0. 000]. Conclusions In congenital dysosmic patients, dysplasia or hypoplasia of olfactory bulbs, tracts and sulei can be clearly depicted on MR images. MR imaging is valuable for clinical diagnosis and treatment.
4.Glioma Stem Cell-Targeted Dendritic Cells as a Tumor Vaccine Against Malignant Glioma.
Baowei JI ; Qianxue CHEN ; Baohui LIU ; Liquan WU ; Daofeng TIAN ; Zhentao GUO ; Wei YI
Yonsei Medical Journal 2013;54(1):92-100
PURPOSE: Cancer stem cells have recently been thought to be closely related to tumor development and reoccurrence. It may be a promising way to cure malignant glioma by using glioma stem cell-targeted dendritic cells as a tumor vaccine. In this study, we explored whether pulsing dendritic cells with antigens of glioma stem cells was a potent way to induce specific cytotoxic T lymphocytes and anti-tumor immunity. MATERIALS AND METHODS: Cancer stem cells were cultured from glioma cell line U251. Lysate of glioma stem cells was obtained by the repeated freezing and thawing method. Dendritic cells (DCs) were induced and cultured from the murine bone marrow cells, the biological characteristics were detected by electron microscope and flow cytometry. The DC vaccine was obtained by mixing DCs with lysate of glioma stem cells. The DC vaccine was charactirizated through the mixed lymphocyte responses and cell killing experiment in vitro. Level of interferon-gamma (IFN-gamma) in the supernatant was checked by ELISA. RESULTS: After stimulation of lysate of glioma stem cell, expression of surface molecules of DC was up-regulated, including CD80, CD86, CD11C and MHC-II. DCs pulsed with lysate of glioma stem cells were more effective than the control group in stimulating original glioma cells-specific cytotoxic T lymphocytes responses, killing glioma cells and boosting the secretion of IFN-gamma in vitro. CONCLUSION: The results demonstrated DCs loaded with antigens derived from glioma stem cells can effectively stimulate naive T cells to form specific cytotoxic T cells, kill glioma cells cultured in vitro.
Animals
;
Antigens, Neoplasm/immunology
;
Apoptosis
;
Brain Neoplasms/*therapy
;
Cancer Vaccines/*therapeutic use
;
Cell Line, Tumor
;
Cell Proliferation
;
Dendritic Cells/*cytology
;
Enzyme-Linked Immunosorbent Assay
;
Flow Cytometry
;
Glioma/*therapy
;
Humans
;
Interferon-gamma/metabolism
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Neoplasm Transplantation
;
Neoplastic Stem Cells/*cytology
;
T-Lymphocytes, Cytotoxic/immunology
5.Three internal fixation devices used for finite element analysis of Pauwels type Ⅲ femoral neck fractures
Yuanbo QI ; Jiantao LI ; Daohong LIU ; Sheng TAO ; Daofeng WANG ; Jie WU
Chinese Journal of Tissue Engineering Research 2024;28(30):4763-4769
BACKGROUND:At present,there is still controversy in clinical practice about the choice of internal fixation of Pauwels type Ⅲ femoral neck fracture,and the selection of internal fixation that provides stable fixation strength is the key basis for achieving Pauwels type Ⅲ fracture fixation. OBJECTIVE:The three-dimensional finite element analysis method was used to test the difference in biomechanical strength of three types of internal fixation in Pauwels type Ⅲ femoral neck fracture,which provided a reference for its clinical treatment. METHODS:Using the CT data of the left femur of a healthy male volunteer,a complete femur and its cancellous bone were reconstructed in Mimics software,and Geomagic studio software was used for reverse modeling.Cannulated compression screw,dynamic hip screw,and femoral neck system were created in UG-NX software.Three kinds of internal fixation models were assembled on the femur model,and Pauwels type Ⅲ femoral neck fracture was simulated by Hypermesh software.Finally,Abaqus software was used to carry out finite element experimental analysis to analyze and compare the stress distribution,stress peak,strain,and displacement distribution caused by fixed femoral neck fracture of different internal fixation systems. RESULTS AND CONCLUSION:(1)The stress of the proximal femur bone mass was mainly distributed in the area below the femoral neck near the fracture end,with the highest stress peak in the dynamic hip screw group and the smallest in the femoral neck system group.(2)The stress distribution of the internal fixation device was mainly concentrated on the screw surface near the fracture line,with the highest stress peak in the femoral neck system group and the smallest in the dynamic hip screw group.(3)The main strain field of the proximal femur bone mass was distributed in the upper surface area where the bone and screw contacted,and the yield strain was the smallest in the femoral neck system group and the largest in the cannulated compression screw group.(4)The main strain field of the internal fixation device model was distributed on the upper surface of the femoral neck screw,with the yield strain being the smallest in the femoral neck system group and the largest in the cannulated compression screw group.(5)The displacement distribution values of femur,proximal bone mass,distal bone block,internal fixation device and internal fixation with the femur as a whole in the three femoral neck fracture internal fixation models decreased gradually from proximal to distal,and the peak displacement of the femoral neck system group was the largest and the lowest in the dynamic hip screw group.(6)The results showed that when the Pauwels type Ⅲ femoral neck fracture was fixed,the stress distribution of femoral neck system was more uniform,the mechanical conduction characteristics were better,and it was subjected to lower yield strain,higher stress and higher displacement.It has relatively better biomechanical stability and can provide a superior mechanical environment for fracture healing.
6.Inhibitory function of Tregs via soluble FGL2 in chronic hepatitis B.
Li XU ; Daofeng YANG ; Yanlin LIU ; Di WU ; Xiaojing WANG ; Qin NING
Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(4):540-545
CD4(+)CD25(+)CD127(dim/-) regulatory T cells (Tregs) have been implicated in suppressing T cell immune responses to hepatitis B virus (HBV), but the inhibition mechanism has not being clear yet. This study investigated the effects of soluble FGL2 (sFGL2) secreted by Tregs on immune suppression in chronic HBV-infected patients. We verified that sFGL2 protein and mRNA were highly expressed in Tregs. The separated Tregs by using magnetic beads from peripheral blood mononuclear cells (PBMCs) in 20 patients with chronic hepatitis B were co-cultured with PBMCs at a ratio of 1:3 with anti-CD3 stimulating antibody or FGL2 blocking antibody. The proliferation index of CD8(+)T cells after blocking FGL2 was higher than that in blank group (3.58±0.18 vs. 3.28±0.17, P=0.034) in 18 of 20 samples, and lower than that in CD3 stimulation group (3.82±0.19, P=0.026) in 16 of 20 samples. The IFN-γ secreted in the mixed culture in the absence of Tregs was higher than that in the culture in the presence of Tregs, but it could be abolished by FGL2 blocking antibody. These results suggest that sFGL2 protein secreted by Tregs suppresses the proliferation and function of CD8(+) T cells in chronic hepatitis B.
CD8-Positive T-Lymphocytes
;
immunology
;
metabolism
;
Cells, Cultured
;
Fibrinogen
;
immunology
;
metabolism
;
Hepatitis B, Chronic
;
immunology
;
metabolism
;
Humans
;
T-Lymphocytes, Regulatory
;
immunology
;
metabolism
7.Study on Prescription Characteristics of Chinese Patent Medicines for Antitussive Effect
Zhang WANG ; Daofeng JIANG ; Yi ZHANG ; Xianli MENG ; Xianrong LAI ; Yamei LI ; Jingzhu WANG ; Long WU ; Yan CHEN ; Yi TAN ; Xue LI ; Yuling QING ; Shaorong QIN ; Jing HUANG ; Tao PENG
World Science and Technology-Modernization of Traditional Chinese Medicine 2013;(8):1759-1765
This study was aimed to reveal characteristics of functions, main indications and applications of Chinese patent medicines in order to provide references for development of new Chinese patent medicines for antitussive ef-fect. Chinese patent medicines recorded in the Pharmacopoeia of the People's Republic of China and the New Na-tional Chinese Patent Medicines were taken as research subjects. Chinese patent medicines classified in the function and indication with key words of cough-relieving, cough-suppressing, cough and chronic cough were col-lected. Analysis was made on the prescription characteristics, such as functions, main indications and applications. The results showed that there were 684 Chinese patent medicines and 462 terms, which were used for a total of 1533 times. The frequently-used terms are antitussive effect with expectorant, antitussive effect, expectorant, heat-clearing and exterior-releasing, antiasthmatic, wind-expelling and antipyretic, antitussive effect with antiasthmatic, purging lung heat, relieving exterior syndrome and moistening the lungs. All 684 Chinese patent medicines were used 48 ma-jor treatments for a total of 1107 times. The main indications include acute and chronic trachitis / bronchitis, exoge-nous wind-heat type of common cold, exogenous wind-cold type of common cold, cough with abundance of phlegm due to phlegm-heat obstructing the lung, acute upper respiratory tract infection, asthma, acute and chronic pharyngi-tis, lung heat cough, and etc. All 684 Chinese patent medicines used a total of 537 kinds of herbs and chemical medicines, including 441 kinds of herbal medicine, 36 kinds of animal medicine, 25 kinds of mineral medicine and 35 kinds of chemical medicine. The top ten herbs in terms of using frequency are Glycyrrhizae radix et rhizoma, Platycodonis radix, Armeniacae semen amarum, Menthae haplocalycis herba, Citri reticulatae pericarpium, Ephedrae herba, Scutellariae radix, Perilla frutescens (L.) Britt, Pinelliae rhizoma, Fritillariae cirrhosae bulbus. Among them, 1/4 of Chinese patent medicines used extract. Five kinds of food or fruits were also used, which were orange, fresh gin-ger, pear, watermelon and dried mushroom. It was concluded that Chinese patent medicines for antitussive effect can be adopted in the treatment of various kinds of diseases, especially for the treatment of cough(heat cough in partic-ular), abundance of phlegm, asthma, pharyngitis, laryngitis, and etc. The treatment methods of clearing heat, dis-pelling wind and relieving exterior syndrome played an important role in the realization of antitussive effect. However, the expression of functions and main indications is far from standardized and clear. Drugs commonly used are herbal medicine plus animal medicine, mineral medicine and chemical medicine as well as food and fruit. The discovery of preparations with certain clinical curative effect from ethnomedicine and the using of their extracts as a major ingre-dient are one important way to develop new Chinese patent medicines with antitussive effect.
8.Development of a C3c-based ELISA method for the determination of anti-complementary potency of Bupleurum polysaccharides.
Mulu WU ; Hong LI ; Yunyi ZHANG ; Daofeng CHEN
Acta Pharmaceutica Sinica B 2015;5(4):316-322
Traditionally, determination of inhibitory potency of complement inhibitors is performed by the hemolytic assay. However, this assay is not applicable to the lectin pathway, thus impeding the understanding of complement inhibitors against the overall function of the complement system. The main objective of our study was to develop a specific enzyme-linked immunosorbent assay (ELISA) as an alternative method to assess the anti-complement activity, particularly against the lectin pathway. By using respective coating substrates against different activation pathways, followed by capturing the stable C3c fragments, our ELISA method can be used to screen complement inhibitors against the classical pathway and the lectin pathway. The inhibitory effect of suramin on the classical pathway, as measured by our hemolytic assay is consistent with previous reports. Further assessment of suramin and Bupleurum polysaccharides against the lectin pathway showed a good reproducibility of the method. Comparison of the lectin pathway IC50 between Bupleurum smithii var. parvifolium polysaccharides (1.055 mg/mL) and Bupleurum chinense polysaccharides (0.98 mg/mL) showed that, similar to the classical and alterative pathway, these two Bupleurum polysaccharides had comparable anti-complementary properties against the lectin pathway. The results demonstrate that the described ELISA assay can compensate for the shortcomings of the hemolytic assay in lectin pathway.